Obesity in the U.S. decreases for first time in decade
The United States was found to be a little bit thinner and healthier in 2023. Research findings show a decrease in obesity for the first time in a decade. Although this percentage is only 0.4%, it ...
Opinion
Medicare should cover anti-obesity drugs
The Centers for Medicare & Medicaid Services has proposed a rule expanding Medicare and Medicaid patients’ access to anti-obesity drugs such as GLP-1s.
2 charts show how spending on most kinds of alcohol has declined in recent decades — especially among young adults
The US Surgeon General released a report directly linking alcohol to cancer. A BI analysis of alcohol spending shows how ...
Axios on MSN2d
Use of diabetes and anti-obesity drugs surges nationwide
Axios Visuals The number of prescriptions for GLP-1 drugs jumped roughly 10% in 2024, according to insurance claims data provided to Axios by health analytics company PurpleLab. Why it matters: The ...
iBio Expands Cardiometabolic and Obesity Program with Anti-Myostatin Antibody Discovered Using its Proprietary Platform, In-Licensed from AstralBio
Building on the success of the anti-Myostatin program, iBio Launches New Program Featuring Myostatin + Activin A Bispecific ...
VKTX Stock Loses More Than 20% in Six Months: Should You Buy the Dip?
Despite the rising competition in the obesity space, we believe that there is room for smaller biotechs like Viking Therapeutics to grab a share of this booming market.